Search results
Results from the WOW.Com Content Network
2010: Endo acquired generic manufacturer Qualitest Pharmaceuticals for $1.2 billion [8] 2011: Endo acquired medical device manufacturer American Medical Systems for more than $2 billion [18] [19] [7] 2013: Endo agreed to purchase Paladin Labs Inc for about $1.6 billion to gain access to the Canadian market as well as expand into emerging markets.
Markey said opposition to expanding methadone access raises questions about profit motivations, as almost 62% of opioid treatment programs are for-profit, some owned by private equity investors ...
This is the list of Schedule II controlled substances in the United States as defined by the ... opiate Codeine [2] 9334 opiate Dihydroetorphine [3] 9190 opiate ...
The Drug Enforcement Administration (DEA) lists oxycodone both for sale and for use in manufacturing other opioids as ACSCN 9143 and in 2013 approved the following annual aggregate manufacturing quotas: 131.5 metric tons for sale, down from 153.75 in 2012, and 10.25 metric tons for conversion, unchanged from the previous year. [172]
NEW YORK (Reuters) -Indivior reached an $86 million settlement with 16 U.S. states over the drug manufacturer's alleged role in spreading opioid addiction across the United States, New York ...
There are fewer than 2,000 opioid treatment programs across the entire country, and as of 2018, 80% of U.S. counties lacked a single clinic. Patients lucky enough to live near one are required ...
The opioid epidemic took hold in the U.S. in the 1990s. Percocet, OxyContin and Opana became commonplace wherever chronic pain met a chronic lack of access to quality health care, especially in Appalachia. The Centers for Disease Control and Prevention calls the prescription opioid epidemic the worst of its kind in U.S. history.
Tapentadol is a novel opioid that displays high affinity and selectivity for the μ-opioid receptor; In a human liability pharmacology study conducted by the sponsor, it was found that tapentadol displays a high abuse potential similar to hydromorphone , a controlled substance with a similar risk of abuse, misuse and diversion; and